Product Information
STEGLATRO 15 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $11.4370 per EA under NDC 00006536406. Its NADAC has been published 406 times since Sep 19, 2018.
Strength
15 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006536406
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERTUGLIFLOZIN PIDOLATEApproval Type
New Drug (NDA)
FDA Application
NDA209803On Market Since
12/19/2017
Price Statistics
The NADAC for STEGLATRO 15 MG TABLET has been published 406 times since Sep 19, 2018, and over the history we have for it it has risen 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4370 per EA |
|---|---|
| All-time high | $11.4463 (Jun 12, 2024) |
| All-time low | $8.5638 (Sep 19, 2018) |
| 52-week high | $11.4370 |
| 52-week low | $11.4235 |
| Median price | $10.3981 |
| Average price | $10.3543 |
| Largest weekly change | +5.0% (Jan 18, 2023) |
| Weeks tracked | 406 |
| Tracking since | Sep 19, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of STEGLATRO 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STEGLATRO 15 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $11.4370 per EA (NDC 00006536406), effective Jun 24, 2026.
How has the price of STEGLATRO 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for STEGLATRO 15 MG TABLET has risen 33.6%. It has been tracked across 406 weekly CMS publications since Sep 19, 2018.
What are the highest and lowest recorded NADAC prices for STEGLATRO 15 MG TABLET?
Since Sep 19, 2018, the NADAC for STEGLATRO 15 MG TABLET has ranged from a low of $8.5638 (Sep 19, 2018) to a high of $11.4463 (Jun 12, 2024), with a median of $10.3981 per EA.
Are there cheaper alternatives to STEGLATRO 15 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, STEGLATRO 15 MG TABLET, is $10.9171 per EA — about 5% below STEGLATRO 15 MG TABLET.
Who manufactures STEGLATRO 15 MG TABLET?
STEGLATRO 15 MG TABLET (NDC 00006536406) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification